✦ LIBER ✦

The clinical use of P300 event related potentials for the evaluation of cholinesterase inhibitors treatment in demented patients

✍ Scribed by E. A. Werber; R. Gandelman-Marton; C. Klein; J. M. Rabey

Publisher: Springer
Year: 2003
Tongue: English
Weight: 198 KB
Volume: 110
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s00702-003-0817-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of donepezil for the treatment of mi

Use of donepezil for the treatment of mild – moderate Alzheimer's disease: an audit of the assessment and treatment of patients in routine clinical practice

✍ Ian Cameron; Stephen Curran; Paul Newton; Duncan Petty; John Wattis 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

Efficacy of three potent steroid sulfata

Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer

✍ Paul A. Foster; Surinder K. Chander; Michael F. C. Parsons; Simon P. Newman; L. 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 385 KB

Evaluating the serial use of the myelofi

Evaluating the serial use of the myelofibrosis symptom assessment form for measuring symptomatic improvement : Performance in 87 myelofibrosis patients on a JAK1 and JAK2 inhibitor (INCB018424) clinical trial

✍ Ruben A. Mesa; Hagop Kantarjian; Ayalew Tefferi; Amylou Dueck; Richard Levy; Kri 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB 👁 1 views

## Abstract ## BACKGROUND: Symptomatic burden from constitutional symptoms, anemia, and splenomegaly‐related symptoms are common and morbidity inducing in patients with myelofibrosis (MF). The authors previously developed a MF‐specific instrument for capturing the burden of MF‐associated disease‐r

Drug resistance mutations and newly reco

Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: Prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients

✍ Carlo Torti; Eugenia Quiros-Roldan; Laura Monno; Andrea Patroni; Annalisa Saraci 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## Abstract This study aimed at identifying HIV‐1 protease amino acid changes associated with protease inhibitor (PI) exposure and susceptibility. New amino acid substitutions were correlated with the number of experienced PIs, reaching statistical significance only for those at positions 3, 44, an